<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80210</article-id><article-id pub-id-type="doi">10.7554/eLife.80210</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Short Report</subject></subj-group><subj-group subj-group-type="heading"><subject>Biochemistry and Chemical Biology</subject></subj-group></article-categories><title-group><article-title>Discovery of a new class of reversible TEA-domain transcription factor inhibitors with a novel binding mode</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-280613"><name><surname>Hu</surname><given-names>Lu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1594-8828</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-280614"><name><surname>Sun</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-280615"><name><surname>Liu</surname><given-names>Shun</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1766-2057</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-280616"><name><surname>Erb</surname><given-names>Hannah</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-277909"><name><surname>Singh</surname><given-names>Alka</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-52979"><name><surname>Mao</surname><given-names>Junhao</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1980-1177</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-4252"><name><surname>Luo</surname><given-names>Xuelian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5058-4695</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-128960"><name><surname>Wu</surname><given-names>Xu</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1624-0143</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor3">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf3"/></contrib><aff id="aff1"><institution content-type="dept">Cutaneous Biology Research Center</institution>, <institution>Massachusetts General Hospital</institution>, <addr-line><named-content content-type="city">Charlestown</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Department of Pharmacology</institution>, <institution>The University of Texas Southwestern Medical Centerh</institution>, <addr-line><named-content content-type="city">Dallas</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Department of Molecular, Cell and Cancer Biology</institution>, <institution>University of Massachusetts Medical School</institution>, <addr-line><named-content content-type="city">Worcester</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-1156"><name><surname>Pan</surname><given-names>Duojia</given-names></name><role>Reviewing editor</role><aff><institution>UT Southwestern Medical Center and HHMI</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>LHU8@mgh.harvard.edu</email> (LH);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>xuelian.luo@utsouthwestern.edu</email> (XL);</corresp><corresp id="cor3"><label>*</label>For correspondence: <email>xwu@cbrc2.mgh.harvard.edu</email> (XW);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>18</day><month>11</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e80210</elocation-id><history><date date-type="received"><day>12</day><month>05</month><year>2022</year></date><date date-type="accepted"><day>11</day><month>11</month><year>2022</year></date></history><permissions><copyright-statement>Â© 2022, Hu et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hu et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-80210-v1.pdf"/><abstract><p>The TEA domain (TEAD) transcription factor forms a transcription co-activation complex with the key downstream effector of the Hippo pathway, YAP/TAZ. TEAD-YAP controls the expression of Hippo-responsive genes involved in cell proliferation, development, and tumorigenesis. Hyperactivation of TEAD-YAP activities is observed in many human cancers, and is associated with cancer cell proliferation, survival and immune evasion. Therefore, targeting the TEAD-YAP complex has emerged as an attractive therapeutic approach. We previously reported that the mammalian TEAD transcription factors (TEAD1-4) possess auto-palmitoylation activities and contain an evolutionarily conserved palmitate-binding pocket (PBP), which allows small molecule modulation. Since then, several reversible and irreversible inhibitors have been reported by binding to PBP. Here, we report a new class of TEAD inhibitors with a novel binding mode. Representative analog TM2 shows potent inhibition of TEAD auto-palmitoylation both <italic>in vitro</italic> and in cells. Surprisingly, the co-crystal structure of the human TEAD2 YAP-binding domain (YBD) in complex with TM2 reveals that TM2 adopts an unexpected binding mode by occupying not only the hydrophobic PBP, but also a new side binding pocket formed by hydrophilic residues. RNA-seq analysis shows that TM2 potently and specifically suppresses TEAD-YAP transcriptional activities. Consistently, TM2 exhibits strong anti-proliferation effects as a single agent or in combination with a MEK inhibitor in YAP-dependent cancer cells. These findings establish TM2 as a promising small molecule inhibitor against TEAD-YAP activities and provide new insights for designing novel TEAD inhibitors with enhanced selectivity and potency.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA219814</award-id><principal-award-recipient><name><surname>Wu</surname><given-names>Xu</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R01CA238270</award-id><principal-award-recipient><name><surname>Wu</surname><given-names>Xu</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK127180</award-id><principal-award-recipient><name><surname>Mao</surname><given-names>Junhao</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000062</institution-id><institution>National Institute of Diabetes and Digestive and Kidney Diseases</institution></institution-wrap></funding-source><award-id>R01DK127207</award-id><principal-award-recipient><name><surname>Mao</surname><given-names>Junhao</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000928</institution-id><institution>Welch Foundation</institution></institution-wrap></funding-source><award-id>I-1932</award-id><principal-award-recipient><name><surname>Luo</surname><given-names>Xuelian</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution>Antidote Health Foundation for the cure of cancer</institution></institution-wrap></funding-source><award-id>postdoc fellowship</award-id><principal-award-recipient><name><surname>Hu</surname><given-names>Lu</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Lu Hu, is an inventor of a patent application covering TM2 and analogues as novel TEAD inhibitors..</p></fn><fn fn-type="conflict" id="conf3"><p>Xu Wu, is an inventor of a patent application covering TM2 and analogues as novel TEAD inhibitors. Dr. Xu Wu has a financial interest in Tasca Therapuetics, which is developing small molecule modulators of TEAD palmitoylation and transcription factors. Dr. Wu's interests were reviewed and are managed by Mass General Hospital, and Mass General Brigham in accordance with their conflict of interest policies..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The crystal structure of TEAD2 YBD in complex with TM2 has been deposited in the Protein Data Bank with accession codes 8CUH. The raw RNA-seq data of NCI-H226 treated with TM2, K975 and VT103 has been deposited in NCBI GEO and is accessible at https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215114.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Wu X</collab><collab>Sun Y</collab><collab>Hu L</collab></person-group><year iso-8601-date="2022">2022</year><source>Next Generation Sequencing Quantitative Analysis of TEAD Inhibitors in NCI-H226 cells</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215114">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE215114</ext-link><comment>NCBI Gene Expression Omnibus, GSE215114</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Hu</collab><collab>L</collab><collab>Sun</collab><collab>Y</collab><collab>Liu</collab><collab>S</collab><collab>Erb</collab><collab>H</collab><collab>Singh</collab><collab>A</collab><collab>Mao</collab><collab>J</collab><collab>Luo</collab><collab>X</collab><collab>Wu</collab><collab>X</collab></person-group><year iso-8601-date="2022">2022</year><source>Discovery of a new class of reversible TEA-domain Transcription factors inhibitors with a novel binding mode</source><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.2210/pdb8CUH/pdb,">https://doi.org/10.2210/pdb8CUH/pdb,</ext-link><comment>Protein Data Bank (PDB), 8CUH</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Calvet L</collab><collab>Dos-Santos O</collab><collab>Spanakis E</collab><collab>Valence S</collab><collab>Jean-Baptiste V</collab><collab>Le Bail J</collab><collab>Buzy A</collab><collab>Paul P</collab><collab>Henry C</collab><collab>Pollard J</collab><collab>Sidhu S</collab><collab>Moll J</collab><collab>Debussche L</collab><collab>Valtingojer I</collab></person-group><year iso-8601-date="2022">2022</year><source>Human malignant mesothelioma NCI-H226 cells treated with TEAD inhibitor K-975 in SCID mice</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196726">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE196726</ext-link><comment>NCBI GEO DataSets, GSE196726</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-80210-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>